Exxonmobil Investment Management Inc. TX decreased its stake in Dentsply International Inc. (NASDAQ:XRAY) by 1.9% during the third quarter, according to its most recent filing with the SEC. The fund owned 59,496 shares of the company’s stock after selling 1,135 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Dentsply International were worth $3,536,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in XRAY. Checchi Capital Advisers LLC boosted its position in Dentsply International by 2.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,007 shares of the company’s stock valued at $125,000 after buying an additional 41 shares in the last quarter. Global X Management Co. LLC boosted its position in Dentsply International by 110.1% in the second quarter. Global X Management Co. LLC now owns 3,169 shares of the company’s stock valued at $197,000 after buying an additional 1,661 shares in the last quarter. Evercore Wealth Management LLC boosted its position in Dentsply International by 12.6% in the second quarter. Evercore Wealth Management LLC now owns 3,204 shares of the company’s stock valued at $199,000 after buying an additional 358 shares in the last quarter. Mizuho Asset Management Co. Ltd. boosted its position in Dentsply International by 170.4% in the second quarter. Mizuho Asset Management Co. Ltd. now owns 3,228 shares of the company’s stock valued at $200,000 after buying an additional 2,034 shares in the last quarter. Finally, Cacti Asset Management LLC purchased a new position in Dentsply International during the second quarter valued at about $203,000. Institutional investors own 93.48% of the company’s stock.

Institutional Ownership by Quarter for Dentsply International (NASDAQ:XRAY)

Dentsply International Inc. (NASDAQ:XRAY) traded down 0.51% during midday trading on Monday, hitting $60.44. The stock had a trading volume of 1,856,353 shares. The company’s 50 day moving average price is $59.17 and its 200-day moving average price is $61.04. Dentsply International Inc. has a 52 week low of $53.43 and a 52 week high of $65.83.

Dentsply International (NASDAQ:XRAY) last issued its earnings results on Friday, November 4th. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.63 by $0.03. Dentsply International had a return on equity of 8.04% and a net margin of 11.15%. The business earned $954.20 million during the quarter, compared to analysts’ expectations of $967.68 million. During the same quarter in the prior year, the firm earned $0.66 EPS. The business’s revenue for the quarter was up 47.0% compared to the same quarter last year. Equities analysts expect that Dentsply International Inc. will post $2.77 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Dentsply International Inc. (XRAY) Shares Sold by Exxonmobil Investment Management Inc. TX” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2016/11/28/dentsply-international-inc-xray-shares-sold-by-exxonmobil-investment-management-inc-tx.html.

Several equities analysts recently issued reports on the company. Zacks Investment Research cut Dentsply International from a “buy” rating to a “hold” rating in a report on Monday, August 8th. Barrington Research cut Dentsply International from an “outperform” rating to a “market perform” rating in a report on Monday, August 8th. Jefferies Group reiterated a “buy” rating on shares of Dentsply International in a report on Wednesday, August 17th. JPMorgan Chase & Co. started coverage on Dentsply International in a report on Thursday, September 22nd. They issued a “neutral” rating and a $65.00 price target on the stock. Finally, Bank of America Corp. started coverage on Dentsply International in a report on Monday, September 12th. They set a “buy” rating and a $70.00 target price on the stock. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company’s stock. Dentsply International presently has a consensus rating of “Hold” and a consensus target price of $67.33.

In other Dentsply International news, VP Rainer Berthan sold 5,000 shares of the company’s stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $61.12, for a total value of $305,600.00. Following the sale, the vice president now owns 34,370 shares in the company, valued at approximately $2,100,694.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO James G. Mosch sold 30,400 shares of the company’s stock in a transaction dated Thursday, November 17th. The shares were sold at an average price of $60.93, for a total value of $1,852,272.00. Following the completion of the sale, the chief executive officer now owns 75,283 shares in the company, valued at approximately $4,586,993.19. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

Dentsply International Company Profile

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Receive News & Stock Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related stocks with our FREE daily email newsletter.